INNO-H
inno-h is an online marketing, advertising, and consulting company.
INNO-H
Social Links:
Industry:
Advertising Digital Marketing Marketing
Address:
Doksansadong, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.inno-h.com
Status:
Active
Contact:
02-6332-6400
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network GStatic Google Static Content PostalAddress Schema LocalBusiness Schema
Similar Organizations
COLON
COLON offers web content, marketing, advertising, and clean energy solutions.
DesignARDOR Creative
DesignARDOR Creative is an online marketing, web promotion and creative solution company.
Flying Concepts
Flying Concepts is an online marketing, advertising, and consulting company.
Marketing Weekly
Niche Marketing knowledge provider and consultants.
THE AGENCY
THE AGENCY is a digital marketing, advertising, and marketing company.
Official Site Inspections
http://www.inno-h.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "inno-h"
HK inno.N
Oct 28, 2024 In the Social (S) area, HK inno.N was selected as a new accredited organization by the Corporate Social Responsibility (CSR) in the Community scheme and also as โฆSee details»
HK inno.N
We, as employees of inno.N, must acknowledge and respect the dignity, values and rights as human beings, must treat both genders equally without distinction in terms of recruitment, task โฆSee details»
HK inno.N
Jan 16, 2024 Geun Seog Song, vice president of R&D in HK inno.N explained, โwe noted the value of cell and gene therapy, a representative player of the advanced therapy medicinal โฆSee details»
Kwak Dal-won - CEO of HK inno.N - koreawho.com
Kwak Dal-won is the CEO and President of HK inno.N. After CJ Healthcare was acquired by Korea Kolmar, its name was changed to HK inno.N. HK inno.N aims to maximize corporate โฆSee details»
์ด๋ ธ์ work.N - workn.inno-n.com
์ด๋ ธ์ work.N์ ์์ง์์ ์ํ ๋ด๋ถ ์์คํ ์ผ๋ก, ์ ๋ฌด ํจ์จ์ฑ์ ๋์ด๊ณ ํ์ ์ ์ง์ํฉ๋๋ค.See details»
HK inno. N Corporation - visitor.cphieventplanner.com
HK inno.N is becoming a global No.1 pharmaceutical player in the global market by expanding exports and strengthening local business.A global pharmaceutical company that the world โฆSee details»
HK inno.N - Crunchbase Investor Profile & Investments
HK inno.N was acquired by Korea Kolmar Co. for $1.1B on Feb 21, 2018. Transaction Name . HK inno.N acquired by Korea Kolmar Co. Acquired by . Korea Kolmar Co. Announced Date Feb 21, 2018; Price $1.1B; IPO & Stock โฆSee details»
HK inno.N Company Description - Stock Analysis
HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers prescription drugs for the treatment of gram-positive and gram-negative organisms, โฆSee details»
Korea Kolmar Co. acquires HK inno.N - 2018-02-21 - Crunchbase
Feb 21, 2018 Acquired Organization: HK inno.N Develops and sells immune anticancer drugs, blood disease drugs, kidney disease drugs, and other products. Acquiring Organization: Korea โฆSee details»
์ฌํ์ฑ ์๊ฒฝ์ - HK์ด๋ ธ์
HK inno.N์ ๏ฝข์ธ๊ณ์ธ๊ถ์ ์ธ(Universal Declaration of Human Rights)๏ฝฃ, ๏ฝข์ ์ ๊ธฐ์ ๊ณผ ์ธ๊ถ ์ดํ ์์น(United Nations Guiding Principles on Business and Human Rights)๏ฝฃ ๋ฐ ๏ฝข๊ตญ์ ๋ ธ๋๊ธฐ๊ตฌ โฆSee details»
IN-M00011 - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 IN-M00011, Initially developed by HK inno.N Corp., Now, its global highest R&D status is Preclinical, Active Org.: HK inno.N Corp.. ... Active Organization. HK inno.N Corp. โฆSee details»
HK inno.Nโs K-CAB chosen as outstanding technology leading โฆ
Nov 7, 2023 HK inno.N's indigenously developed drug K-CAB (tegoprazan) has been recognized as an outstanding technology that has contributed to the development of the Korean industry. โฆSee details»
HK์ด๋ ธ์ - inno-n.com
HK์ด๋ ธ์(HK inno.N)์ด ๊ตญ์ ํ์ค ์ค๋ฒ๊ฒฝ์์์คํ ์ธ โISO 37301โ์ ๋์ ํ๋ค. ์ ์ธ๊ณ์ ์ผ๋ก ESG ๊ฒฝ์์ ๋ํ ๊ด์ฌ์ด ๋์์ง๋ฉด์ โISO37301โ์ ์ค์์ฑ์ด ์ ์ฐจ ์ปค์ง๊ณ ์๋ ๋งํผ HK์ด๋ ธ์๋ ISO โฆSee details»
IN-B00008 - Drug Targets, Indications, Patents - Synapse - Patsnap
IN-B00008, Initially developed by HK inno.N Corp., Now, its global highest R&D status is Phase 3, Therapeutic Areas: Endocrinology and Metabolic Disease,Skin and Musculoskeletal Diseases, โฆSee details»
HK inno.Nโs GERD drug K-CAB recommended for approval in India
Dec 2, 2024 HK inno.N said Monday that it received a recommendation for approval of its gastroesophageal reflux disease (GERD) treatment, K-CAB tablets, from the Subject Expert โฆSee details»
IN-A010 - Drug Targets, Indications, Patents - Synapse
IN-A010, Initially developed by HK inno.N Corp., Now, its global highest R&D status is Pending, Therapeutic Areas: Digestive System Disorders,Eye Diseases. ... Originator Organization. HK โฆSee details»
HK์ด๋ ธ์ - inno-n.com
Hk์ด๋ ธ์(hk inno.n)์ด ์ค๊ธฐ์ธํฌ์์ ์ ๋ํ ์์์ข ์น๋ฃ์ ๊ฐ๋ฐ์ฉ ์ธํฌ์ฃผ ์ํ์์ฐ์ ์ถ์งํ๋ค. ๊ฒฝ๊ธฐ๋ ํ๋จ์ ๊ตฌ์ถํ hk์ด๋ ธ์์ ์ธํฌ์ ์ ์์น๋ฃ์ ์ผํฐ์์ ์งํํ๋ ๊ฒ์ผ๋ก, hk์ด๋ ธ์์ ์์ฒด โฆSee details»
IN B001 - AdisInsight - Springer
Jan 28, 2023 20 Nov 2020 HK inno.N Corporation plans a phase I trial for Coxsackievirus infections (Prevention) in South Korea in December 2020 (NCT04637919) 18 Jun 2020 CJ โฆSee details»
22ND-01 - Drug Targets, Indications, Patents - Synapse
Dec 21, 2024 Accelerate Strategic R&D decision making with Synapse, PatSnapโs AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.See details»